文献速递白血病

异柠檬酸脱氢酶突变与急性髓系白血病中改变的IL-1β反应相关

Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemia.
PubMed 文献 · Leukemia · 2021-12-02

研究使用同基因细胞系模型,发现IDH2突变细胞对IL-1β的下游读出显著更敏感,RNA测序证实细胞因子相关信号通路和NF-κB靶基因增加,单细胞RNA测序确认IL-1β转录反应改变,靶向抑制IKK复合物可减少IL-1β反应并诱导原代IDH突变白血病样本细胞死亡。

要点

  • IDH2突变细胞对IL-1β多个下游读出显著更敏感。
  • IDH2突变细胞中细胞因子相关信号通路和NF-κB靶基因增加。
  • 靶向抑制IKK复合物减少IL-1β反应并诱导原代IDH突变白血病样本细胞死亡。

核心结论

  • 结果证实IDH2突变细胞中IL-1β信号改变,并将该通路确定为潜在治疗靶点。

研究设计与样本

  • 使用同基因细胞系模型研究IDH2突变细胞的分化和信号反应。
  • 采用磷酸化特异性流式细胞术和质谱流式细胞术检测下游读出。
  • 进行批量RNA测序和单细胞RNA测序分析转录反应。
  • 使用原代IDH突变白血病样本进行IKK复合物靶向抑制实验。

主要发现

  • IDH2突变细胞对IL-1β多个下游读出显著更敏感。
  • 批量RNA测序证实细胞因子相关信号通路和NF-κB靶基因增加。
  • 单细胞RNA测序确认未刺激和刺激的IDH2突变细胞中IL-1β转录反应改变。
  • 靶向抑制IKK复合物减少IL-1β反应并诱导原代IDH突变白血病样本细胞死亡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mutations in isocitrate dehydrogenase 2 (IDH2) have been noted to impact cellular differentiation in addition to DNA and histone methylation. However, little is known about the impact of IDH2 mutations on intracellular signaling. Using an isogenic cell line model, we investigated both differentiation and signaling responses in IDH2 mutant cells and show augmented responses to inflammatory immune ligands. Using phospho-specific flow and mass cytometry, we demonstrate IDH2 mutant cells were significantly more sensitive to IL-1β at multiple downstream readouts. Further, bulk RNA sequencing confirmed increases in cytokine-related signaling pathways and NF-κB target genes. Single-cell RNA sequencing of unstimulated and stimulated cells confirmed altered IL-1β transcriptional responses in the IDH2 mutant cells. Targeted inhibition of the IKK complex reduced IL-1β responses and induced cell death in primary IDH-mutated leukemia samples. Together, these results confirm altered IL-1β signaling in IDH2 mutant cells and identify this pathway as a potential therapeutic target.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Sunthankar KI, Jenkins MT, Cote CH, et al. Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemia. Leukemia. 2021. PMID: 34857894. doi:10.1038/s41375-021-01487-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。